An overview on the efficacy of herbs used in ayurvedic formulations for the treatment of type 2 diabetes by Kandunuri, Kiran Kumar et al.
 ~ 116 ~ 















Kiran Kumar Kandunuri 
Doctoral Researcher, School of 
Human sciences, Faculty of Life 





Director, Molecular Systems for 
Health Research Group School of 
Human Sciences Faculty of Life 
Sciences & Computing London 
Metropolitan University, 
Holloway Road London 
 
Eileen Smith 
Senior Lecturer in 
Pharmaceutical Sciences, School 
of Human Sciences Faculty of 
Life Sciences& Computing 
London Metropolitan University 



































Kiran Kumar Kandunuri 
Doctoral Researcher, School of 
Human sciences, Faculty of Life 











An overview on the efficacy of herbs used in ayurvedic 
formulations for the treatment of type 2 diabetes 
 
Kiran Kumar Kandunuri, Kenneth White and Eileen Smith 
 
Abstract 
Ayurvedic herbs are proven to provide symptomatic relief and prevention of secondary complications of 
diabetes. Though mainstream treatment is effective in controlling the disease, it is expensive and has 
adverse side effects. Ayurvedic formulations have the ability to regenerate pancreatic beta cells, while 
possessing antioxidant and cholesterol lowering properties. The present review is focused on highlighting 
characteristics of prominent anti-diabetic herbs and their hypoglycaemic activities that have shown 
proven cellular, pre-clinical or clinical evidences. Poly herbal formulations of multiple herbal extracts are 
also discussed. The promising nature of herbal therapy is compared against mainstream therapy. Despite 
the promising nature of the herbal therapy for treatment of diabetes the majority of the herbs have 
remained unexplored to their full potential. Therefore, it is important to highlight their potentials and 
ascertain their therapeutic properties and benefits.  
 




People are resorting to herbal therapy as an alternative for mainstream therapy with a 
perception that it is a natural remedy for diabetes [1]. Despite that, only limited hypoglycaemic 
herbs have been researched for their efficacy. This article aims to review up to date findings on 
the efficacy, side effects of herbs. Mainstream drugs tend to establish glucose homeostasis 
either by promoting insulin secretion or by glucose uptake by muscle cells [2]. These drugs 
known to have adverse side effects [3]. Administration of external insulin does not always 
matches the cell demands and oral anti diabetic agents have limitations. Both do not establish 
complete glucose homeostasis and also in long term usage drug resistance would develop. 
These disadvantages encourage patients to adapt to alternative therapies such as Ayurveda. In 
Ayurveda, individual and poly herbal formulations are widely used and will have synergistic 
effects [4]. Although, Ayurvedic formulations have been used conventionally as herbal 
remedies for centuries, to date only limited research has been conducted on the therapeutic 
benefits of Ayurvedic formulations for managing type 2 diabetes. However, it is commonly 
reported that, herbal remedies cause fewer side-effects relative to pharmacological 
interventions and could provide a natural alternative or an adjunct therapy to other 
interventions. The purpose of this review is to look at the open literature related to commonly 




The search terms used for the compilation of the relevant articles are ayurvedic hypoglycaemic 
formulations, anti-diabetic ayurvedic drugs, anti-diabetic phytochemicals, Indian anti-diabetic 
medicinal plants, hypoglycaemic herbal drugs, alternative therapies for diabetes, 
complimentary therapies for diabetes, traditional drugs for diabetes, and diabetes treatment. 
And also the names of 9 generally cited anti-diabetic ayurvedic herbs are searched using the 
following tools: PubMed, Medline, Allied and Complementary Medicine, Ovid MEDLINE, 
BIOSIS Previews, EMBASE, AMED and The Cochrane library. In addition, the names of 4 
prominent anti-diabetic herbal formulations are searched in World Wide Web, and compiled in 
the literature search.  
 
3. Results 
Ayurvedic hypoglycaemic herbs 
There are many anti-diabetic herbs used in Ayurveda, the most commonly prescribed 
individual herbs are summarized below (herbs are described using botanical names). 
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Azadirachta indica Linn (Neem) 
Aqueous extracts of Azadirachta promotes antioxidant 
protection in diabetic rat [5]. Leaf extract and seed oil 
promotes glucose uptake in normal and diabetic rabbits and 
this effect is similar to Glibenclamide [6]. Leaf extracts 
demonstrated ulcer healing effects in normal and in diabetic 
rats. The mechanism inducing the effects was studied on 
number of parameters such as offensive acid-pepsin secretion 
and defensive mucin secretion in mucosal cells in rats [7]. Leaf 
extract promotes anti-hyperglycaemic activity in diabetic rats 
without altering serum cortisol level [8]. Meliacinolin is a 
derivative of Azadirachta, which behaves as an insulin 
sensitizer and improves renal function, lipid profile, and 
antioxidant activity. Meliacinolin may interact with multiple 
targets involved in diabetes pathogenesis. Meliacinolin 
inhibits α-Glucosidase and α-amylase enzymes which lowers 
the levels of post prandial hyperglycaemia and prevent the 
absorption of carbohydrates [9]. A clinical study showed that 
administration of Azadirachta leaf powder, aqueous extract 
and alcoholic extract at higher doses for 14 days promotes 
hypoglycaemic activity [10]. Beta-sitosterol is a steroid 
obtained from Azadirachta indica, may be source for its 
hypoglycemic activity [11]. 
 
Berberis aristata Linn (Daruharidhra/Darvi/Darurajani) 
Alkaloids such as Berberine, Berbamine, Aromoline, 
Karachine, Palmatine, Oxycanthine and Oxyberberine [12] are 
major constituents in Berberis aristata. A study shown that 
active principle like Berberine, encourages glucose-stimulated 
insulin secretion rather than basal insulin secretion in dose-
dependent manner in rat’s pancreatic islets [13]. This 
insulinotropic effect is aided by hepatic nuclear factor 4 alpha 
and glucokinase, and this mechanism is different from 
sulphonylurea class of drugs [14]. In a study to stimulate 
glucose uptake activity, application of 50 µM Berberine along 
with 0.2 nM insulin in 3T3-L1 adipocytes have shown that the 
level of insulin increased by 10 nM, which pronounced the 
efficacy of Berberine. It augmented glucose transporter-4 
translocation into the plasma membrane by enhancing insulin 
signalling pathways and the insulin receptor substrate-1-
phosphoinositide 3 Kinase-Akt. Application of Berberine in 
Min6 cells improved insulin secretion and proliferation with 
the help of enhanced insulin/insulin-like growth factor-1 
signalling cascade. These observations were proving the 
efficacy of berberine as an insulin sensitizing and 
insulinotropic agent [13]. 
It is also found that Berberine exhibits striking glucose uptake 
activity in human hepatoma cells in a comparative study with 
other phytochemicals such as Phloretin, Ouabain and 
Metformin. It is observed that Berberine is promoting more 
glucose uptake activity than Metformin [15]. 
 
Cinnamon zeylaniucm Linn (Tvak/Dalchini) 
In an experiment Cinnamon promoted a compound known as 
IRS-1 in rats, which promotes glucose uptake in muscle tissue 
by promoting insulin secretion. It is also promotes the glucose 
uptake from the blood stream to muscle tissue by influencing 
Glucose transporter 4 [16, 17]. The role of Cinnamon in treating 
diabetes was published in the journal of Diabetes Care in 
2003 by Khan and colleagues [18]. This study was conducted 
with 60 patients around the age of 50. The patients were 
divided into six groups of 10 patients and Groups 1 through 3 
were treated with 1, 3, or 6 grams of Cinnamon on daily for 
40 days, while Groups 4 through 6 were given placebo. The 
researchers analysed the fasting glucose, LDL cholesterol, 
triglycerides and total cholesterol. The results revealed that no 
significant changes were observed in the placebo group over 
the 40-days period. While for the treated groups, the 
reductions in fasting glucose (reduced by18 percent to 29 
percent), triglycerides (reduced by 23 percent to 30 percent), 
LDL cholesterol (reduced by 7 percent to 27 percent) and 
total cholesterol (reduced by12 percent to 26 percent) were 
observed. Also high dosage and long-term consumption of 
Cinnamon was found to be safe. A similar study was also 
performed in Germany where 79 patients with type 2 diabetes 
were examined. In this study, half of the patients received 
placebo the rest received 3 grams of Cinnamon daily for four 
months. In this study no difference between the two groups 
was reported for LDL or HDL cholesterol, triglycerides or 
HgbA1c, while fasting glucose levels dropped about 7 percent 
more in the group receiving Cinnamon [19]. In another study, 
25 post-menopausal women with type 2 diabetes were treated 
with 1.5 grams of Cinnamon daily for six weeks and reported 
that Cinnamon was not associated with a significant change in 
insulin sensitivity, glucose tolerance or cholesterol profile. In 
a similar manner another study concluded that Cinnamon did 
not improve HgbA1c, fasting glucose or blood lipids in 
patients with either type 1 or type 2diabetes [20]. There are 
several evidences suggest that Cinnamon extracts contain 
components that enhance insulin action but effects of 
cinnamon on non-insulin stimulated glucose uptake need 
further investigation. A study reported on the effects of 
cinnamaldehyde on the glucose transport activity of GLUT1 
in L929 fibroblast cells under both basal and insulin-
stimulated conditions where glucose uptake is activated by 
glucose deprivation. The result concluded that 
cinnamaldehyde has a dual action on the glucose transport 
activity of GLUT1. Under basal conditions it stimulates 
glucose uptake and reaches a 3.5 fold maximum stimulation at 
2.0mM. However, cinnamaldehyde also inhibits the activation 
of glucose uptake by glucose deprivation in a dose dependent 
manner. Further to this, experiments with cinnamaldehyde 
analogs have shown that these activities are fully dependent 
on the structural motif of the α,β-unsaturated aldehyde in 
cinnamaldehyde. The inhibitory activity of cinnamaldehyde 
was continued even after a wash and recovery period. Pre-
treating cinnamaldehyde with thiol-containing compounds, 
such as β-mercaptoethanol or cysteine, blocks the inhibitory 
activity of cinnamaldehyde. The results suggest that 
cinnamaldehyde inhibits the activation of GLUT1 by forming 
a covalent link to target cysteine residues. This dual activity 
suggests that cinnamaldehyde is not a major contributor to the 
anti-diabetic properties of cinnamon [21].  
 
Gymnema sylvestre Linn (Gurmar/Meshashringi) 
A study using crude extracts of Gymnema and dihydroxy 
gymnemic triacetate are exerted hypoglycemic effect in 
streptozotocin induced diabetic rats [22]. This effect is induced 
by Gymnemic acids that delay the glucose release into the 
bloodstream. The glucose absorption by the intestines is 
prevented since Gymnemic acid molecules fill the receptor 
located in the absorptive external layers of the intestine. The 
crude extract which contains dihydroxy gymnemic triacetate 
helps to release insulin by the stimulation of regeneration of 
the remaining beta cells [23]. Studies have also shown that 
aqueous extract of Gymnema sylvestre leaves have the ability 
to stimulate insulin secretion in mice cells and isolated human 
islets in vitro [24]. It is also revealed that the plasma glucose 
and insulin levels when measured in the healthy rats with a 
dose of dihydroxy gymnemic triacetate were not changed and 
further suggesting that it is a normoglycemic compound. 
Hydroxy gymnemic triacetate isolated from Gymnem 
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asylvestre lowers the blood glucose levels and biochemical 
parameters in streptozotocin induced diabetic rats [22]. 
Extensive clinical trials on human subjects are required for 
further exploring the prospects of the compound to be used as 
a drug. Gurmar powder which is prepared from Gymnema 
sylvestre leaves is one of the main ayurvedic product used for 
the treatment of diabetes. It correlates the metabolic activities 
of liver, kidney and muscle tissues and stimulates insulin 
secretion and also exerts blood glucose lowering effect. It also 
inhibits the intestinal absorption of sugars, there by prevents 
blood sugar variations and also it is a diuretic and cardiac 
stimulant. It is also a sugar buster, that when taken it prevents 
the taste buds from absorbing sugar molecules which 
discourages glycosuria [25, 1]. 
 
Momordica charntia Linn. (Karela/ Kareli/ Karavella/ 
Kathilla/ Sushavi) 
Studies have shown that application of Momordica charantia 
extract causes substantial lowering of peripheral blood 
glucose and elevates the level of plasma insulin in diabetic 
rats. This effect was due to regeneration of pancreatic beta 
cells in treated rats. Known anti-diabetic phytochemicals such 
as Momordicin, Charantin and insulin like protein, galactose 
binding lectin were isolated from different parts of the plant 
and the separated compounds proved to possess insulin 
mimetic activity [26]. Aqueous extracts of unripen, green fruits 
partially displaying insulin release activity in isolated beta 
cells of obese diabetic mice and that is indicating insulin 
stimulation and releasing action is the effect of perturbations 
of beta cell membranes [27, 28]. Momordica charantia promotes 
renewal of beta cells in the pancreas or promote the recovery 
of partially damaged beta cells and further stimulate insulin 
secretion [29]. Due to its intrinsic nature of pancreatic beta cell 
regeneration, physicians are prescribing active constituents of 
this herb as an adjuvant for type 2 diabetic 
patients [30, 31]. Bitter gourd powder (Momordica charantia) 
plays important role in Ayurveda for the treatment of 
diabetes. It contains glycosides, saponins, alkaloids, reducing 
sugars, phenolics, oils, free acids, polypeptides, sterols, 17-
amino acids including methionine and a crystalline product 
named p-insulin. It is documented for its hypoglycemic 
activity along with anti-haemorrhoidal, astringent, stomachic, 
emmenagogue, hepatic stimulant, anthelmintic and blood 
purifier activities. It also promotes immunity against general 
infections, exerts lowering of blood and urine sugar levels [32]. 
 
Pterocarpus marsupium Linn (Vijaysar/Pitashalaka/Bijaka/ 
Pitasara) 
Active principles in Pterocarpus marsupium such as 
Epicatechin, Pterosupin, Marsupin and Pterostilbene are 
known to promote insulin sensitivity [33] and Marsupin, 
Pterosupin and Liquiritigenin also demonstrates anti-
hyperlipidemic activity [34]. Epicatechin promotes insulin 
secretion, insulin release and adaptation of proinsulin to 
insulin in vitro experiments. Epicatechin increases glycogen 
content of rat diaphragm in a dose-dependent manner and 
encourages oxygen uptake in adipose cells and tissues of 
different organs by its insulin mimicking nature [35]. Tannates 
in the Pterocarpus marsupium extract promotes anti diabetic 
activity. Pancreatic beta cell regeneration has been observed 
after application of flavonoid fraction [36]. 
In a multi-centre clinical trial, Pterocarpus marsupium was 
studied for glucose lowering effect and to determine adverse 
side effects compared with a standard pharmacological agent 
Tolbutamide. It is concluded that Pterocarpus is as effective 
as Tolbutamide in the management of type 2 diabetes without 
any adverse side Effects [37]. 
 
Syzygium cumini Linn. (Jambu/Badijamun) 
Mycaminose is an active principle isolated from Syzygium 
seed extract. In a study, Mycaminose, ethyl acetate and 
methanol extracts of S. cuminiseeds were administered to 
diabetic rats and significant reduction in blood glucose level 
was noticed. This effect is comparable with standard drug 
Glibenclamide. Bark extracts stimulate the insulin positive 
cells from the pancreatic duct epithelial cells [38]. 
 
Tinospora cordifolia Linn. (Guduchi/Giloe/ Gurcha) 
A study has shown that administration of extracts of 
Tinospora cordifolia decreases the blood glucose level and 
increases glucose tolerance in rodents. The oral administration 
of root extracts for about 6 weeks in alloxan induced diabetic 
rats caused a decrease in glucose level in blood, urine and also 
a decrease of lipids in serum, brain and tissues, while an 
increase of body weight is also observed. A dosage of 400 
mg/kg aqueous extract could cause significant anti-
hyperglycemic effect in animal models [39, 40].  
 
Trigonella foenum-graecum Linn. (Methi/Medhika) 
4-Hydroxyisoleucine is prominent amino acid in Trigonella 
and it exhibits insulin-stimulating characteristics [41]. The 
prominent isomer of 4-hydroxyisoleucine, which is a typical 
branched-chain amino acid, that derived from fenugreek 
seeds, is responsible for the effects on glucose and lipid 
metabolism in experimental rats and proves to increase 
glucose stimulated insulin release by isolated islet cells in 
rats, mice and humans [1, 41, 42]. In vitro and in vivo studies 
have shown that 4-hydroxyisoleucine promotes glucose-
induced insulin release [43]. The fibre content in seeds 
promotes insulin sensitivity, by slowing down carbohydrate 
metabolism that leads to reduced insulin levels and lowers 
blood glucose. The anti- hyperglycaemic effect of the seed 
extracts, powder and gum of fenugreek seeds and leaves are 
related to slow gastric emptying because of its high fibre 
content and also inhibition of carbohydrate digestive enzymes 
and stimulation of insulin secretion [44]. Syndrex is an 
ayurvedic product used for the treatment of diabetes, in which 
main ingredient is germinated fenugreek extract. It lowers 
blood sugar in people with diabetes and promotes slow 
absorption of sugars in the intestines and stimulates insulin 
[45]. 
 
4. Polyherbal formulations 
Mixture of antidiabetic herbs is also used in Ayurveda, 
commonly known as polyherbal formulation. Some of the 
well-known polyherbal formulations are Ayush-82, Diabecon, 
Epiinsulin and Diabeta. The characteristics of the individual 
formulations are summarised below. 
 
Ayush-82  
Ayush-82 is a blend of following four herbs: Syzygium 
cuminii, Momordica charantia, leaves of Gymnema sylvestre 
and the seeds of Mangifera indica [46, 47]. It exerts glucose 
lowering effects and these are prominent polyherbal 
formulation in Ayurveda. Further study is needed in order to 
consolidate their effectiveness. 
 
Diabecon 
It is a combination of herbs consist of Gymnema sylvestre, 
Pterocarpus marsupium, Glycyrrhiza glabra, Casearia 
esculenta, Syzygium cumini, Asparagus racemosus, Boerhavia 
diffusa, Sphaeranthus Indicus, Tinospora cordifolia, Swertia 
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chirata, Tribulus terrestris, Phyllanthus amarus, Gmelina 
arborea, Gossypium herbaceum, Berberis aristata, Aloe vera, 
Triphala, Commiphora wightii, shilajeet, Momordica 
charantia, Piper nigrum, Ocimum sanctum, Abutilon indicum, 
Curcuma longa, Rumex maritimus. It reduces long term 
diabetic complications and acts like insulin analog and 
discourages glycated haemoglobin levels. It also encourages 
repair, regeneration and protects beta cells from oxidative 
stress. In addition, it increases c peptide level, peripheral 
utilization of glucose, enhances hepatic and muscle glucagon 
levels and normalizes the microalbuminuria and regulates the 
lipid profile [48]. 
 
Epi insulin 
It is a combination of active principles such as Epicatechin 
and Benzopyran. Epicatechin stimulates eleveated Insulin 
secretion by promoting cAMP content of islets of langerhans. 
It raises cathepsian activity which converts proinsulin to 
insulin. Due to its insulin mimicking nature, it promotes 
osmotic hemolysis and inhibits Na/K ATPase activity in red 
blood cells. It promotes glucose and lipid metabolisms, 
therefore encouraging comprehensive health. Although the 
use is limited to treatment of type 2 diabetes, it can also be 
used as an adjuvant for the treatment of type 1 diabetes to 
reduce the amount of external insulin administration. Due to 
its gentle hypoglycemic nature, generally prescribers 
recommend epiinsulin as preventive medication for potential 
diabetic patients and as an adjuvant for established patients [1]. 
 
Diabeta 
The formulation is a blend of Gymnema sylvestre, 
Vincarosea, Curcuma longa, Azadirachta, Pterocarpus 
arsupium, Momordica charantia, Syzygium cumini, Acacia 
arabica, Tinospora cordifolia and Zingiber officinale. Diabeta 
promotes comprehensive health to the patients and gives 
symptomatic relief. It corrects and prevents degenerative 
complications of diabetes with its effective mechanism of 
action on omnious octet. It can be used as an adjuvant for 
main stream drugs in order to prevent resistance to oral 
hypoglycemic drugs [1]. 
 
5. Discussion 
The mainstream oral anti-diabetic drugs have adverse side 
effects such as rapid drop in blood glucose level, lactic 
acidosis, liver damage, neurologic deficits, hypoglycaemia 
,weight gain, back pain, upper respiratory infections, nausea, 
cramps, diarrhoea, lactose intolerance , vitamin B-12 
deficiency, digestive disorders, intestinal gas formation, fluid 
retention, anaemia and menstrual problems [3]. These 
disadvantages with mainstream anti diabetic drugs encourage 
diabetic patients to adapt to alternative therapies such as 
Ayurveda because of its affordability and it is proven to cause 
less side effects. Since Ayurvedic herbal formulations 
constituted mainly plant extracts or intact herbs, they are rich 
in antioxidants and essential nutrients which promote 
comprehensive health without adverse side effects even after 
prolonged administration. Herbal drugs are comparatively 
cheaper than synthetic drugs. One of the known issues with 
the Ayurvedic herbal formulation is heavy metal toxicity [49] 
which often leads to heavy metal poisoning risk to the patient 
[50-52]. To date there is no proper scientific evidence for safety, 
efficacy and understanding of herbal medicines. Therefore 
patients undergoing herbal treatment might be unknowingly 
exposing themselves to the risks of toxicity or overdose. Due 
to the absence of a clear understanding of the mechanisms of 
the apparent therapeutic effect, the progression of many 
promising herbs have been hindered to date. Large proportion 
of the side effects when herbal medications are consumed are 
attributable to the poor quality of herbal drugs resulting from 
contamination of raw ingredients and incorporation of heavy 
metals in order to enhance their potency. Ironically, plant-
derived phytochemicals are secondary metabolites and these 
are not always benign molecules and many of them express 
toxicity up on application [53]. Therefore, it is vital to 
implement proper cultivation, harvestation and production 
processes and adapting modern analytical techniques and 
international regulation to enhance the quality of herbal drugs 
[54]. 
Regardless of above limitations, by implication of proper 
scientific methods, tools and further investigation of well-
known anti-diabetic herbs in traditional medicine may provide 
a new understanding for valuable resources for innovative, 
evidence-based and effective treatment solutions for the 
treatment of diabetes.  
 
Conclusion 
To date, the active principles of many hypoglycaemic herbs 
have not been well characterized. Further investigations must 
be carried out in order to evaluate the mechanism of action of 
ayurvedic herbs which exhibits insulin mimetic activity. 
Though there is a perception that generally herbs are safe to 
consume, many herbal formulations are not safe due to the 
issues such as heavy metal toxicity, and therefore toxicity 
study should be elucidated. It is important to isolate, purify, 
elucidate structure and conduct cellular, preclinical and 
clinical studies of Ayurvedic Hypoglycemic herbs, in order to 
innovate better alternatives for treatment of type 2 diabetes. 
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